Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JRNYS vs Nalena

JRNYS
Graded #267

Lower grade

vs+8.700000000000003
Nalena
Graded #97

Higher grade

The verdict

Nalena takes it — 71.2/100 to 62.5/100.

Nalena grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNalena +29
45
74
Dose & formulationNalena +6
58
64
Clinical oversightJRNYS +2
84
82
Labs & monitoringJRNYS +18
71
53
FulfillmentNalena +24
65
89
Contract termsNalena +6
55
61
JRNYS · left barNalena · right bar

The numbers

MetricJRNYSNalena
WeighScore62.5/10071.2/100
GradeCC
Scorecard rank#267#97
SemaglutideNot disclosed$149/mo (starting dose, compounded)
TirzepatideNot disclosed$149/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
JRNYS

Graded #267 · C

Strengths

  • Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
  • The membership band is published before intake and is banded openly by level of coach support
  • Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
  • Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
  • Members with commercial insurance may pay around $25 a month for the medication after any deductible

Where it loses points

  • The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
  • No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
  • The best case depends on commercial insurance coverage; without it the medication cost is unknown
  • No compounded option is disclosed — the programme is brand-focused, and brand list prices are the dearest route to a GLP-1
  • The states it can prescribe in are not published
Nalena

Graded #97 · C

Strengths

  • Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
  • Transparent fee model: no hidden fees, no membership, cancel anytime
  • Money-back guarantee — uncommon among compounded telehealths
  • Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
  • Women-focused positioning

Where it loses points

  • Per-dose pricing not published — only the 'starting at $149' entry price
  • No LegitScript, HIPAA, or NABP badges on public pages
  • Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
  • Houston address looks like a virtual office rather than a clinical facility
  • No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard